Treatment of CP‐initiated autoimmune diseases may be most effective when using complement inhibitory drugs targeting the very initiation of the CP, for example by C1‐esterase inhibitor or sutimlimab,24 both inhibiting the CP protease C1s.64, 65, 66, 67. This evidence concerns the gene CP and autoimmune disease.